| PERIOD ENDING | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | | Total Revenue | 33,516 | 24,586 | 27,852 | 26,815 | | Cost of Revenue | 1,523 | 1,174 | 1,193 | 66,186 | | | Gross Profit | 31,993 | 23,412 | 26,659 | (39,371) | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 32,570 | 25,031 | 27,476 | (35,152) | | Non Recurring |
-
|
-
|
-
| 12,999 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (577) | (1,619) | (817) | (17,218) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | (577) | (1,619) | (817) | (17,218) | | Interest Expense | 291 | 309 | 325 | 361 | | Income Before Tax | (868) | (1,928) | (1,142) | (17,579) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (868) | (1,928) | (1,142) | (17,579) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (868) | (1,928) | (1,142) | (17,579) | | Preferred Stock And Other Adjustments | (96) | (84) | (85) | (85) | | | Net Income Applicable To Common Shares | ($964) | ($2,012) | ($1,227) | ($17,664) |
|
0.83% Nasdaq 0.00%
Income Statement
